ArticleCancer medicine2017

Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.

Hiroyuki Kitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.